A controlled trial of oral sodium cromoglycate in atopic eczema

Abstract

A placebo-controlled double-blind crossover trial of oral sodium cromoglycate was undertaken in thirty children with atopic eczema, employing the dosage and administration schedule recommended by the manufacturers. No difference was detected between the effects of 4 weeks' treatment with sodium cromoglycate and placebo.